SLC6A2 and neuroblastoma: Approximately 90% of neuroblastomas express the norepinephrine transporter (NET) [2], enabling the application of meta-iodobenzylguanidine (MIBG), a structural analogue of norepinephrine, for imaging and treatment purposes.